시장보고서
상품코드
1149183

디지털 병리학 : 각종 기술과 세계 시장

Digital Pathology: Technologies and Global Markets

발행일: | 리서치사: BCC Research | 페이지 정보: 영문 191 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 디지털 병리학 시장 규모는 2022년 59억 달러에서 2027년에는 107억 달러로 증가하며, 2022-2027년의 CAGR은 12.5%로 예측됩니다.

북미 지역은 2022년 24억 달러에서 2027년에는 43억 달러로 증가하며, CAGR은 12.2%로 추정되고 있습니다. 또한 아시아태평양은 2022년 13억 달러에서 2027년에는 26억 달러로 증가하며, CAGR은 14.1%로 추정되고 있습니다.

세계의 디지털 병리학 시장을 조사했으며, 기술의 정의·개요, 발전 경위, 사례 연구, 특허 동향, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 각종 부문·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

  • 디지털 병리학의 현재 동향
  • 원격병리진단 및 디지털 병리학 시장의 정의, 진화, 통합
  • 기존 프로세스와 디지털 병리학·코스트 워크
  • 주요 연구 분야에서의 영상 분석과 중요성
  • 임상시험에서의 디지털 병리학
  • 디지털 병리학 : EHR·EMR·기타 정보 시스템
  • 규제 환경
  • 기술 동향
  • 디지털 병리학 : 선진국 vs 신흥 경제국
  • 중동·아프리카의 디지털 병리학 시장 동향
  • 시장 정보
  • 기술 이동 : 디지털 병리학 컴포넌트로부터 통합 시스템으로의 이동
  • 디지털 시장 부문별 개요
  • 이미징 용도에서의 존재감을 높이기 위한 계약·제휴
  • 디지털 병리학 시스템 혁신의 기반으로서의 미국
  • 전략적 결론
  • 사례 연구
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 과제·기회
  • COVID-19의 영향

제4장 디지털 병리학 시스템 시장

  • AI 실장에서의 과제
  • 디지털 병리학 디바이스 시장
    • 가상 현미경·가상 슬라이드
    • 디지털카메라
    • 로봇 현미경
    • 이미지 센서
    • 스캐너
  • 디지털 병리학 애널리틱스 시장
    • 가시화·영상 분석 플랫폼
    • 디지털 병리학 정보 관리 시스템
  • 디지털 병리학 스토리지 시장
  • 통신 플랫폼 시장
    • 디지털 병리학에서 웹 기반 또는 클라우드 기반 커뮤니케이션 플랫폼
    • 실시간 모니터링과 액션을 가능하게 하는 IoMT(Internet of Medical Things)
    • EHR의 채택 증가
    • 클라우드 AI에 의한 진단의 향상
    • 지방에 헬스케어를 가져오는 원격의료
    • 디지털 트윈 : 안전한 테스트 환경을 실현
  • 원격병리진단 시스템
    • 원격병리진단 시스템의 주요 이점
    • 정지화면 기반 시스템
    • 하이브리드 원격병리진단 시스템
    • 실시간 원격병리진단 이미징 시스템

제5장 디지털 병리학 시장에서의 체외 및 기타 진단 디바이스

  • 자동 혈액 분석기 및 혈구 카운터
    • 혈액 분석기 컴포넌트와 기구
    • 혈액학 기기 소프트웨어
    • 제조업체의 관점에서 본 혈액 기기
    • 첨단 혈액 분석기 모델 시장
    • 표준 혈액 분석기 모델 시장
    • 디지털 셀 카운터의 특징
    • 현재의 제품과 기능
  • 디지털 염색체 분석기
  • 형광 in situ 하이브리다이제이션 계수 시스템
  • 디지털 요침사 분석기
  • 면역조직화학 영상 분석 애플리케이션
  • 디지털 세포 병리
  • 디지털 중합효소 연쇄 반응
  • 인환세포 검출
  • 디지털 홀로그래픽 현미경

제6장 디지털 병리학 시장 : 유형별

  • 해부 병리
    • 디지털 병리 시스템과 해부 병리 검사 정보 시스템의 통합을 위한 주요 고려사항
    • 유전병리
  • 혈액 및 임상 병리
  • 면역 병리
  • 화학 병리
  • 법의학 병리
  • 미생물

제7장 디지털 병리학 시장 : 용도별

  • 질환 진단
  • Drug Discovery·의약품 개발
  • R&D

제8장 최종사용자 시장

  • 바이오테크놀러지·제약회사
  • 병원·진단 센터
  • 학술 센터·기타

제9장 지역 시장 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제10장 경쟁 구도

  • 신제품의 개발
  • 기타 주요 전략

제11장 특허 분석

제12장 기업 개요

  • 3DHISTECH LTD.
  • APOLLO ENTERPRISE IMAGING CORP.
  • CLINISYS
  • CORISTA
  • F. HOFFMANN-LA ROCHE LTD.
  • HURON TECHNOLOGIES INTERNATIONAL INC.
  • INDICA LABS INC.
  • INSPIRATA INC.
  • LEICA BIOSYSTEMS INC.
  • LIGOLAB INFORMATION SYSTEMS LLC
  • MIKROSCAN TECHNOLOGIES INC.
  • NIKON INSTRUMENTS INC.
  • VISIOPHARM
  • XIFIN
KSA 22.11.17

Highlights:

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

North American digital pathology market is estimated to increase from $2.4 billion in 2022 to reach $4.3 billion by 2027, at a CAGR of 12.2% from 2022 through 2027.

Asia-Pacific digital pathology market is estimated to increase from $1.3 billion in 2022 to reach $2.6 billion by 2027, at a CAGR of 14.1% from 2022 through 2027.

Report Scope:

This report includes forecasted trends and sales in the digital pathology markets through 2027. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends, and competitive scenarios that will form the base data for qualitative analysis and market estimates.

The digital pathology and telepathology market have been analyzed for the four main geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and information generated from pathology labs and that regarding specific diagnosis; but it will exclude general hospital-based mHealth issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.

Report Includes:

  • 52 data tables and 32 additional tables
  • An up-to-date overview and analysis of the global markets for digital pathology technologies
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market opportunities for the digital pathology market, industry specific growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and market forecast for digital pathology in value (USD millions) terms, and their corresponding market share analysis by system, type, application, end-user, and geographic region
  • In-depth information (facts and figures) concerning major market dynamics, technology updates, new products and applications, and COVID-19 impact on the market for digital pathology
  • Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2027
  • Updated information on key mergers and acquisition deals, agreements, collaborations and product launches within the digital pathology industry
  • A relevant patent analysis
  • Analysis of the company competitive landscape for digital pathology market, and company value share analysis based on segmental revenues and key financial performance
  • Profile descriptions of the leading global companies, including CliniSys, F. Hoffmann-La Roche Ltd., Leica Biosystems Inc., Nikon Instruments Inc., and XIFIN Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Study Background
  • 1.3 Scope of Report
  • 1.4 Intended Audience
  • 1.5 Information Source and Methodology
  • 1.6 What's New in This Update?
  • 1.7 Analyst's Credentials
  • 1.8 BCC Custom Research
  • 1.9 Related BCC Research Reports

Chapter 2 Executive Summary

Chapter 3 Market Overview

  • 3.1 Current Trends in Digital Pathology
    • 3.1.1 Collaborations to Develop Better Solutions
    • 3.1.2 Innovations to Surge Market Growth
    • 3.1.3 Cloud Computing to Enhance Healthcare Delivery Systems
    • 3.1.4 Digital and Computational Pathology
  • 3.2 Telepathology and Digital Pathology Market Definition, Evolution and Integration
    • 3.2.1 Key Markets for Digital Telepathology
  • 3.3 Conventional Process Versus Digital Pathology and Cost Works
  • 3.4 Image Analysis and Its Importance in Key Research Areas
  • 3.5 Digital Pathology in Clinical Trials
  • 3.6 Digital Pathology: Electronic Health Records, Electronic Medical Records and Other Information Systems
  • 3.7 Regulatory Environment
    • 3.7.1 United States
    • 3.7.2 United Kingdom
  • 3.8 Technology Trends
    • 3.8.1 Scanning Speeds and Image Resolutions
    • 3.8.2 Viewing Advancements and Clinical Decision Support
    • 3.8.3 Archival Standards
    • 3.8.4 Multi-Site Collaboration Applications
    • 3.8.5 Whole-Slide Digital Imaging
    • 3.8.6 Cloud Computing and Digital Pathology
    • 3.8.7 Laboratory Information Systems
  • 3.9 Digital Pathology: Developed Versus Developing Economies
  • 3.10 The Middle East and African Digital Pathology Market Trends
  • 3.11 Market Intelligence
  • 3.12 Technology Transition: Digital Pathology Components to Integrated Systems
  • 3.13 Digital Market Segment Overview
    • 3.13.1 Whole-Slide Imaging
    • 3.13.2 Laboratory Information Management System
    • 3.13.3 Medical Imaging Informatics
  • 3.14 Agreements and Collaborations to Enhance Presence in Imaging Applications
  • 3.15 U.S. as the Base for Digital Pathology System Innovation
  • 3.16 Strategic Conclusions
  • 3.17 Case Studies
    • 3.17.1 Case Study 1: Digital Pathology Enabling Critical Diagnosis
    • 3.17.2 Case Study 2: Initiatives and Examples of Telepathology Deployment in Developing Economies
    • 3.17.3 Case Study 3: Digital Pathology's Role in Cost Savings Among Big Pharma Companies
    • 3.17.4 Case Study 4: Digital Pathology in Resource-poor Settings
    • 3.17.5 Case Study 5: Health Evaluation Centers in Vietnam -- Business Model of Medical Support of Foreign Countries with WSI Telepathology
    • 3.17.6 Case Study 6: Complete Digital Pathology for Primary Diagnosis, Two Years on: The Experience at Granada 3.17.1 University Hospitals, Spain
    • 3.17.7 Case Study 7: Telepathology in Mongolia
    • 3.17.8 Case Study 8: The Prostate Cancer Image Epidemiology Project: Toward Model-based Histopathology, Sweden
    • 3.17.9 Case Study 9: A Financial Projection for Digital Pathology Implementation at a Large, Integrated Healthcare Organization
  • 3.18 Market Dynamics
    • 3.18.1 Drivers
    • 3.18.2 Restraints
    • 3.18.3 Challenges and Opportunities
  • 3.19 Impact of the COVID-19 Pandemic
    • 3.19.1 Introduction
    • 3.19.2 Impact on Digital Pathology Market

Chapter 4 Digital Pathology System Market

  • 4.1 Challenges in Implementing AI
  • 4.2 Digital Pathology Devices Market
    • 4.2.1 Virtual Microscopy and Virtual Slides
    • 4.2.2 Digital Cameras
    • 4.2.3 Robotic Microscopes
    • 4.2.4 Image Sensors
    • 4.2.5 Scanners
  • 4.3 Digital Pathology Analytics Market
    • 4.3.1 Visualization and Image Analysis Platforms
    • 4.3.2 Digital Pathology Information Management Systems
  • 4.4 Digital Pathology Storage Market
    • 4.4.1 Vendor-Neutral Archive
  • 4.5 Communication Platform Market
    • 4.5.1 Web-based or Cloud-based Communication Platforms in Digital Pathology
    • 4.5.2 Internet of Medical Things (IoMT) Enabling Real-time Monitoring and Action
    • 4.5.3 Increased Adoption of Electronic Healthcare Records (EHRs)
    • 4.5.4 Artificial Intelligence (AI) on the Cloud to Facilitate Better Diagnostics
    • 4.5.5 Telemedicine Bringing Healthcare to Rural and Remote Areas
    • 4.5.6 Digital Twins Enable Safe Testing Environments
  • 4.6 Telepathology Systems
    • 4.6.1 Key Advantages of Telepathology Systems
    • 4.6.2 Static Image-based Systems
    • 4.6.3 Hybrid Telepathology Systems
    • 4.6.4 Real-time Telepathology Imaging Systems

Chapter 5 In Vitro and Other Diagnostic Devices in the Digital Pathology Market

  • 5.1 Automated Hematology Analyzers and Blood Cell Counters
    • 5.1.1 Hematology Analyzer Components and Mechanics
    • 5.1.2 Hematology Instrument Software
    • 5.1.3 Hematology Instrumentation from the Manufacturer's Perspective
    • 5.1.4 Advanced Hematology Analyzer Model Market
    • 5.1.5 Standard Hematology Analyzer Model Market
    • 5.1.6 Digital Cell Counter Features
    • 5.1.7 Current Products and Features
  • 5.2 Digital Chromosome Analyzers
  • 5.3 Fluorescence In Situ Hybridization Enumeration Systems
  • 5.4 Digital Urine Sediment Analyzers
  • 5.5 Immunohistochemistry Image Analysis Applications
  • 5.6 Digital Cytopathology
  • 5.7 Digital Polymerase Chain Reaction
    • 5.7.1 Digital Polymerase Chain Reaction Applications
    • 5.7.2 Digital Polymerase Chain Reaction Advantages
    • 5.7.3 Real-Time Versus Traditional Versus Digital Polymerase Chain Reaction
  • 5.8 Signet Cell Detection
  • 5.9 Digital Holographic Microscopy

Chapter 6 Digital Pathology Market by Type

  • 6.1 Anatomical Pathology
    • 6.1.1 Key Considerations for Integrating Digital Pathology Systems with Anatomy Pathology Laboratory Information Systems
    • 6.1.2 Genetic Pathology
  • 6.2 Hematology and Clinical Pathology
  • 6.3 Immunopathology
  • 6.4 Chemical Pathology
  • 6.5 Forensic Pathology
  • 6.6 Microbiology

Chapter 7 Digital Pathology Market by Application

  • 7.1 Disease Diagnosis
  • 7.2 Drug Discovery and Drug Development
    • 7.2.1 Digital Image Uses
  • 7.3 Research and Development

Chapter 8 End-User Market

  • 8.1 Biotech and Pharma Companies
  • 8.2 Hospitals and Diagnostic Centers
  • 8.3 Academic Centers and Others

Chapter 9 Regional Market Analysis

  • 9.1 North America
  • 9.2 Europe
    • 9.2.1 Case Study: Implementation Issues for Virtual Microscopy in Europe
  • 9.3 Asia-Pacific
    • 9.3.1 China
    • 9.3.2 India
  • 9.4 Rest of the World (RoW)

Chapter 10 Competitive Landscape

  • 10.1 New Product Development
  • 10.2 Other Key Strategies

Chapter 11 Patent Analysis

  • 11.1 U.S. Patent Analysis
  • 11.2 European Patent Analysis
  • 11.3 Japan Patent Analysis
  • 11.4 List of Patents

Chapter 12 Company Profiles

  • 3DHISTECH LTD.
  • APOLLO ENTERPRISE IMAGING CORP.
  • CLINISYS
  • CORISTA
  • F. HOFFMANN-LA ROCHE LTD.
  • HURON TECHNOLOGIES INTERNATIONAL INC.
  • INDICA LABS INC.
  • INSPIRATA INC.
  • LEICA BIOSYSTEMS INC.
  • LIGOLAB INFORMATION SYSTEMS LLC
  • MIKROSCAN TECHNOLOGIES INC.
  • NIKON INSTRUMENTS INC.
  • VISIOPHARM
  • XIFIN
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제